Déclaration hebdomadaire des transactions sur actions propres du 28 septembre 2026 au 2 octobre 2026

Nexans reported purchasing 15,000 of its own shares under its buyback program during the stated period of September 28–October 2, 2026, with daily totals of 3,000 shares and reported weighted average prices ranging from €132.6020 to €136.1946. Natixis executed the transactions under the stated market-abuse regulation exemption; the filing is factual and does not announce a change to the program.

Analysis

The key distinction is that this is not evidence of a discretionary capital-return bid: the stated MAR Article 5(2)(c) purpose is consistent with meeting employee share-plan obligations. If acquired shares are later delivered to employees, the economic benefit is mainly dilution management, not a durable reduction in shares outstanding. The reported 15,000 shares imply roughly €2 million of purchases at the disclosed average prices—likely too small to change earnings or valuation absent evidence that it is large relative to Nexans’ normal trading volume or annual share awards. Near term, the program may provide modest, price-insensitive demand; it does not establish management’s view of intrinsic value. The contrarian risk is reading routine execution as a bullish buyback signal and paying for support that can disappear when the mandate pauses. In the next 1–3 months, the useful catalyst is evidence of the program’s actual scale and treatment of repurchased shares, not this filing alone. Longer term, the investment case remains tied to operating delivery, cash generation and award-related dilution. Data-quality caveat: the summary table’s 10/1 and 10/2 dates conflict in format with the detailed 01/10 and 02/10 records; confirm the filed dates and totals before using daily activity in a flow model.

Key Decisions for Investors

• No trade on this disclosure alone; do not treat the purchases as a signal of undervaluation or a material EPS tailwind.
• For existing NEX exposure, regard the activity as a small near-term flow cushion only. Reassess if subsequent filings show materially larger purchases, a different stated purpose, or cancellation rather than employee-plan delivery.
• Verify the date-format discrepancy and reconcile the 3,000-share daily aggregates against the detailed transactions; monitor future filings for cumulative volume, mandate duration and shares ultimately delivered or retired.
• Falsification/watch item: if repurchases cease while the share price weakens, the assumed marginal flow support is absent; if reported share count and employee-award issuance do not improve, the dilution-offset thesis is not being realized.